TBRG

NEUTRALM&A

TruBridge, Inc.

2026-06-24

Price

$26.18

+0.19%

This is the 2026-06-24 snapshot — the signals and analysis for TBRG as of this single trading day.

View full TBRG research hub →

Score11.0Top Tier

Signals5/8 DNA0/13 Act · 0/4 Risk

SentimentNEUTRALScore: 8

Volume1.1xvs 20d avg

Analysis

TruBridge's highly stable technical signals and low realized volatility are the direct result of its pending all-cash acquisition by IKS Health for $26.25 per share. The expiration of the Hart-Scott-Rodino (HSR) antitrust waiting period just 48 hours ago cleared a major regulatory hurdle, causing the stock to pin tightly to its buyout price. Furthermore, the current RISK_ON macro regime and pristine credit environment—highlighted by 0.74% OAS spreads—virtually eliminate any financing risk for the buyer, giving institutional arbitrageurs high conviction that the deal will close successfully.

Fired Signals

ALPHA MALEQUIET STORMSTEADY CLIMBGOLDEN CROSSPERFECT STACK

Key Takeaways

Merger Arbitrage Dynamics: TBRG is trading at $26.18, acting as a fixed-income proxy with a narrow spread up to the $26.25 all-cash buyout price.
Regulatory Milestone Achieved: The expiration of the HSR waiting period on June 22 removes a critical regulatory barrier, locking in the STEADY_CLIMB and QUIET_STORM technical signals.
Macro Deal Support: The ultra-low credit spread environment ensures zero liquidity stress, providing high confidence that the $400 million acquisition will not face financing hurdles.

← Back to 2026-06-24 View Full TBRG History →Yahoo Finance &nearr;